Consensus estimate for Arvinas Inc (ARVN)’s next quarter EPS at -$1.49

Arvinas Inc (NASDAQ: ARVN) closed the day trading at $39.04 down -3.37% from the previous closing price of $40.40. In other words, the price has decreased by -$1.36 from its previous closing price. On the day, 615679 shares were traded.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Ratios:

For a better understanding of ARVN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.98 and its Current Ratio is at 4.98. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on February 28, 2024, Reiterated its Outperform rating but revised its target price to $80 from $95 previously.

On February 14, 2024, Citigroup Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $36 to $55.

On February 01, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $70.Goldman initiated its Buy rating on February 01, 2024, with a $70 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 23 ’24 when Houston John G sold 5,196 shares for $47.05 per share. The transaction valued at 244,472 led to the insider holds 1,036,681 shares of the business.

Cassidy Sean A sold 1,702 shares of ARVN for $80,079 on Feb 23 ’24. The Chief Financial Officer now owns 181,916 shares after completing the transaction at $47.05 per share. On Feb 23 ’24, another insider, Taylor Ian, who serves as the Chief Scientific Officer of the company, sold 1,701 shares for $47.05 each. As a result, the insider received 80,032 and left with 147,522 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARVN now has a Market Capitalization of 2.66B and an Enterprise Value of 1.40B. For the stock, the TTM Price-to-Sale (P/S) ratio is 33.86 while its Price-to-Book (P/B) ratio in mrq is 4.02. Its current Enterprise Value per Revenue stands at 17.84 whereas that against EBITDA is -3.55.

Stock Price History:

Over the past 52 weeks, ARVN has reached a high of $53.08, while it has fallen to a 52-week low of $13.57. The 50-Day Moving Average of the stock is 45.15, while the 200-Day Moving Average is calculated to be 30.64.

Shares Statistics:

Over the past 3-months, ARVN traded about 748.10K shares per day on average, while over the past 10 days, ARVN traded about 487.78k shares per day. A total of 68.00M shares are outstanding, with a floating share count of 58.38M. Insiders hold about 14.26% of the company’s shares, while institutions hold 89.46% stake in the company. Shares short for ARVN as of Mar 15, 2024 were 7.92M with a Short Ratio of 10.59, compared to 7.77M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.64% and a Short% of Float of 12.98%.

Earnings Estimates

Current recommendations for the stock of the company come from 17 analysts. On average, analysts expect EPS of -$1.41 for the current quarter, with a high estimate of -$0.95 and a low estimate of -$2.42, while EPS last year was -$1.54. The consensus estimate for the next quarter is -$1.49, with high estimates of -$1 and low estimates of -$2.56.

Analysts are recommending an EPS of between -$4.06 and -$7.3 for the fiscal current year, implying an average EPS of -$5.8. EPS for the following year is -$6.04, with 17 analysts recommending between -$2.19 and -$8.8.

Revenue Estimates

10 analysts predict $35.07M in revenue for the current quarter. It ranges from a high estimate of $50M to a low estimate of $25M. As of the current estimate, Arvinas Inc’s year-ago sales were $32.5M, an estimated increase of 7.90% from the year-ago figure. For the next quarter, 10 analysts are estimating revenue of $34.87M, a decrease of -36.00% less than the figure of $7.90% in the same quarter last year. There is a high estimate of $50M for the next quarter, whereas the lowest estimate is $25M.

A total of 15 analysts have provided revenue estimates for ARVN’s current fiscal year. The highest revenue estimate was $230M, while the lowest revenue estimate was $100M, resulting in an average revenue estimate of $142.77M. In the same quarter a year ago, actual revenue was $78.5M, up 81.90% from the average estimate. Based on 15 analysts’ estimates, the company’s revenue will be $212.91M in the next fiscal year. The high estimate is $412M and the low estimate is $100M. The average revenue growth estimate for next year is up 49.10% from the average revenue estimate for this year.

Most Popular